Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP

NCT01364883 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oxford